KT-939: A Next-Generation Human Tyrosinase Inhibitor With Superior Efficacy for the Safe Management of Hyperpigmentation.

Saved in:
Bibliographic Details
Title: KT-939: A Next-Generation Human Tyrosinase Inhibitor With Superior Efficacy for the Safe Management of Hyperpigmentation.
Authors: Hou X; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Li Y; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Zhang Q; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Yan H; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Zhang X; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Yang Y; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Cai X; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Wang J; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Ding M; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Chen D; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Chen J; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Tong Y; Kintor Pharmaceutical Limited, Suzhou, Jiangsu, China., Mehta N; The University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Goren A; University of Rome 'G. Marconi', Rome, Italy.
Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2025 Nov; Vol. 24 (11), pp. e70510.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print Cited Medium: Internet ISSN: 1473-2165 (Electronic) Linking ISSN: 14732130 NLM ISO Abbreviation: J Cosmet Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1473-2165
DOI:10.1111/jocd.70510